Electric fields and immunotherapy join forces against hard-to-treat lung cancer
Disease control
Ongoing
This study tests a wearable device that sends low-intensity electric fields to tumors, combined with the immunotherapy drug pembrolizumab, in people with advanced non-small cell lung cancer that has worsened after prior treatments. The goal is to see if this combination helps peo…
Phase: PHASE2 • Sponsor: NovoCure GmbH • Aim: Disease control
Last updated May 17, 2026 03:13 UTC